Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 217 of 1,261
  1. US 11548887

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  2. US 11547101

    Non-human animals having a disruption in a C9ORF72 locus

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  3. US 11547664

    Compositions and methods for treating eosinophilic disorders

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  4. US 11548943

    Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  5. US 11549110

    Modified short interfering nucleic acid (siNA) molecules and uses thereof

    Aligos Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  6. US 11548944

    Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  7. US 11547687

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  8. US 11548888

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  9. CY 2022006

    ΠΡΟΦΑΡΜΑΚΑ ΦΟΥΜΑΡΙΚΩΝ ΑΛΑΤΩΝ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΣΤΗΝ ΑΓΩΓΗ ΠΟΙΚΙΛΩΝ ΝΟΣΩΝ

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 5, 2023 · Expires Dec 31, 2042

    granted
  10. AR 123726

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA Y TIENO[3,2-H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Jan 4, 2023 · Expires Dec 30, 2042

    granted
  11. US 11542504

    Compounds and methods for modulating ATXN1

    Ionis Pharmaceuticals, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  12. US 11542410

    Coatings containing enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  13. US 11542304

    Multimeric bicyclic peptide ligands

    BicycleTx Limited · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  14. US 11542538

    Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates

    Northwestern University · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  15. US 11541002

    Oral film compositions and dosage forms having precise active dissolution profiles

    Aquestive Therapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  16. US 11542526

    Oncolytic adenoviral vector and methods of use

    Unleash Immuno Oncolytics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  17. US 11542506

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  18. US 11542560

    Microbiome markers and therapies for autism spectrum disorders

    Board of Regents on Behalf of Arizona State University · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11542486

    Human kynureninase enzyme variants having improved pharmacological properties

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  20. US 11542341

    Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  21. US 11542338

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  22. US 11542320

    Nucleic acids encoding single domain antibodies to chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  23. US 11542275

    Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  24. US 11542312

    IL-2 superagonists in combination with anti-PD-1 antibodies

    Medicenna Therapeutics Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.